Hereditary spherocytosis in children: profile and post-splenectomy outcome

Anirban Das1, Deepak Bansal, Reena Das

  • 1Pediatric Hematology-oncology unit, Advanced Pediatric Center and *Department of Hematology, PGIMER, Chandigarh, India. Correspondence to: Dr Deepak Bansal, Hematology-oncology unit, Department of Pediatrics, Advanced Pediatric Center, PGIMER, Chandigarh, India. deepakbansaldr@gmail.com.

Indian Pediatrics
|March 18, 2014
PubMed

Insights

Hereditary spherocytosis in children presents with anemia, enlarged spleen and liver, and jaundice. Post-splenectomy sepsis is rare in these patients.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Genetics

Background:

  • Hereditary spherocytosis (HS) is a genetic hemolytic anemia.
  • It is characterized by abnormal red blood cell shape and splenic sequestration.
  • HS presents with variable clinical severity in children.

Purpose of the Study:

  • To characterize the clinical profile of pediatric hereditary spherocytosis.
  • To analyze diagnostic features and management outcomes over 27 years.

Main Methods:

  • Retrospective analysis of case records.
  • Involved 82 children diagnosed with hereditary spherocytosis between 1985 and 2011.

Main Results:

  • Mean age at diagnosis was 6.7 years; 8.5% diagnosed in infancy.
  • Common findings included pallor (100%), splenomegaly (96%), hepatomegaly (73%), and jaundice (67%).
  • Gallstones occurred in 26%; 32% underwent splenectomy with 7.7% developing post-splenectomy sepsis.

Conclusions:

  • Anemia, hepato-splenomegaly, and jaundice are key clinical features of pediatric HS.
  • Splenectomy is a treatment option, and post-splenectomy sepsis is infrequent.
Abstract